Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook
Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year ...
Wednesday, March 18, 2026
Tag: Biogen
Here’s What Analysts Think About Biogen Inc. (BIIB)
Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several rating updates on ...
Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)
Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking ...
Biogen – BIIB: Leqembi erhält Zulassungen in China & Australien!
Pullback-Setup mit Bullenflagge! Neuausrichtung bei Biogen (BIIB): Alcyone Therapeutics für rund 85 Millionen USD übernommen & Rückzug aus AAV-basierten Gentherapieprojekten! ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.